Predictive approaches to increase absorption of compounds during lead optimisation

Bibliography

• Kay C. Introduction. In: Tsaioun K, Kates SA, editors. ADMET for medicinal chemists – a practical guide. Wiley, Hoboken, New Jersey, USA; 2011. p. 1-28
   Google Scholar
• Morgan P, Van Der Graaf PH, Arrowsmith J, et al. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving phase II survival. Drug Discov Today 2012;17:419-24
   PubMed Web of Science ®Google Scholar
• Lipinksi CA, Lombardo F, Dominy BW, Feeny PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25
   Web of Science ®Google Scholar
• Wenlock MC, Austin RP, Barton P, et al. A comparison of physiochemical property profiles of development and marketed oral drugs. J Med Chem 2003;46:1250-6
   PubMed Web of Science ®Google Scholar
• Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem 2000;43:3867-77
   PubMed Web of Science ®Google Scholar
• Teague S, Davis AM, Leeson PD, Oprea TI. The design of leadlike combinatorial libraries. Angew Chem Int Ed 1999;38:3743-8
   PubMed Web of Science ®Google Scholar
• Rishton GM. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today 2003;8:86-96
   PubMed Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng H-Y, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45:2615-23
   PubMed Web of Science ®Google Scholar
• Chemspider Chemical Database. Available from: http://www.chemspider.com/ RSC, Advancing the Chemical Sciences
   Google Scholar
• ChemAxon. Available from: http:/www.chemaxon.com
   Google Scholar
• Bahl SK, Kassam K, Peirson IG, Pearl GM. The rule of five revisited: applying log D in place of log P in drug-likeness filters. Mol Pharm 2007;4:556-60
   PubMedGoogle Scholar
• Lipinski CA, Davis AL, Aldrige PK, Brown CW. Biologically relevant UV-based solubility assays. Pharmaceutical Analysis Session, 45th Pittsburgh Conference; Chicago; 1994. Oral presentation 959
   Google Scholar
• Bevan CD, Lloyd RS. A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 2000;72:1781-7
   PubMed Web of Science ®Google Scholar
• Pan L, Ho Q, Tsutsui K, Takahashi L. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J Pharm Sci 2001;90:521-9
   PubMed Web of Science ®Google Scholar
• Colclough N, Hunter A, Kenny PW, et al. High throughput solubility determination with application to selection of compounds for fragment screening. Bioorg Med Chem 2008;16:6611-16
   PubMed Web of Science ®Google Scholar
• Collander R, Bärlund H. Permeabilitätstudien an Chara eratophylla. Acta Botanica Fennica 1932;11:72-114
   Google Scholar
• Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeability assay in the description of passive absorption processes. J Med Chem 1998;41:1007-10
   PubMed Web of Science ®Google Scholar
• Sugano K, Hamada H, Machida M, Ushio H. Hogh throughput prediction of oral absorption: improvement of the composition of the lipid solution used in parallel artificial membrane. J Biomol Screen 2001;6:189-96
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd H, Smith DA, Beaumont K, Walker DK. Property-based design: optimization of drug absorption and pharmacokinetics. J Med Chem 2001;44:1313-33
   PubMed Web of Science ®Google Scholar
• Sha'afi RI, Gary-bobo CM, Solomon AK. Permeability of red cell membranes to small hydrophilic and lipophilic solutes. J Gen Physiol 1971;58:238-58
   PubMed Web of Science ®Google Scholar
• Camenish G, Folkers G, van de Waterbeemd H. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. Pharm Acta Helv 1996;71:309-27
   PubMedGoogle Scholar
• Hill AP, Hyde RM, Robertson AD, et al. Oral delivery of 5-HT1D receptor agonists: towards the discovery of 311c90, a novel anti-migraine agent. Headache 1994;34:308-9
   Google Scholar
• Hersey A. ADME in-silico models – Tools for drug discovery. Presentation at UK-QSAR Autumn Meeting; 2002. Available from: http://www.ukqsar.org/2011/07/12/autumn-meeting-2002/
   Google Scholar
• Young R. Physical Chemistry: A medicinal chemist's perspective. Physchem Forum 5. 2008. Available from: http://physchem.net/Symp05/symp05.htm
   Google Scholar
• Borthwick AD, Davies DE, Exall AM, et al. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics and in vivo potency. J Med Chem 2006;49:4159-70
   PubMed Web of Science ®Google Scholar
• Valkó K. Measurements and predictions of physico-chemical properties. In: Darvas F, Dorman GY, eitords High-throughput ADMETox estimation: in vitro and in silico approaches. Biotechnologies Press, Westborough, MA; 2002. p. 1-24
   Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the Biopharmaceutics Classification System. Eur J Pharm Biopharm 2004;58:265-78
   PubMed Web of Science ®Google Scholar
• Butler J, Dressman J. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci 2010;99:4940-54
   PubMed Web of Science ®Google Scholar
• Johnson TW, Dress KR, Edwards M. Using the golden triangle to optimize clearance and oral absorption. Bioorg Med Chem Lett 2009;19:5560-4
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Fleisher D. Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci 1985;74:588-9
   PubMed Web of Science ®Google Scholar
• Macheras PE, Symillides MY. Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm Drug Dispos 1989;10:43-53
   PubMed Web of Science ®Google Scholar
• Sanghvi T, Ni N, Yalkowski SH. A simple modified absorption potential. Pharm Res 2001;18:1794-6
   PubMed Web of Science ®Google Scholar
• Ni N, Sanghvi T, Yalkowski SH. Independence of the product of solubility and distribution coefficient of pH. Pharm Res 2002;19:1862-6
   PubMed Web of Science ®Google Scholar
• Johnson KC, Swindell AC. Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm Res 1996;13:1795-8
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-49
   PubMed Web of Science ®Google Scholar
• Sun D, Yu LX, Hussain MA, et al. In vitro testing of drug absorption for drug “developability” assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel 2004;7:75-85
   PubMed Web of Science ®Google Scholar
• Zhao Y, Le J, Abraham MH, et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure – activity relationship QSAR with the Abraham descriptors. J Pharm Sci 2001;90:749-84
   PubMed Web of Science ®Google Scholar
• Absolv, software for calculating the Abraham molecular descriptors, Advance Chemistry Laboratories. Available from: http://acdlabs.com
   Google Scholar
• Zhao YH, Abraham MH, Hersey A, Luscombe CN. Quantitative relationship between rat intestinal absorption and Abraham descriptors. Eur J Med Chem 2003;38:939-47
   PubMed Web of Science ®Google Scholar
• Beaumont K, Gardner I, Chapman K, et al. Toward an integrated human clearance prediction strategy that minimizes animal use. J Pharm Sci 2011;100(10):4518-35
   PubMed Web of Science ®Google Scholar
• Cao X, Gibbs ST, Fang L, et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 2006;23(8):1675-86
   PubMed Web of Science ®Google Scholar
• Klopman G, Stefan LR, Saiakhov RD. ADME evaluation 2. A computer model for prediction of intestinal absorption in humans. Eur J Pharm Sci 2002;17:253-63
   PubMed Web of Science ®Google Scholar
• Martin YC. A bioavailability score. J Med Chem 2005;48:3164-70
   PubMed Web of Science ®Google Scholar
• Dressman JB, Thelen K, Willmann S. An update on computational oral absorption simulation. Expert Opin Drug Metab Toxicol 2011;11:1345-61
   Google Scholar
• Gastroplus, software from Simulation Plus, Inc. Available from: http://www.simulations-plus.com/Products.aspx?grpID=3&cID=16&pID=11
   Google Scholar
• Willmann S, Lipper J, Sevestre M, et al. PK-Sim: a physiologically based pharmacokinetic‘whole-body' model. Biosilico 2003;1:121-4
   Google Scholar
• Hintz RJ, Johnson KC. The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm 1989;51:9-17
   Web of Science ®Google Scholar
• Kesisoglou F, Wu Y. Understanding the effect of API properties on bioavailability through absorption modelling. AAPS J 2008;10:516-25
   PubMed Web of Science ®Google Scholar
• Lewis DF, Ito Y. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity. Xenobiotica 2009;39:625-35
   PubMed Web of Science ®Google Scholar
• Dobson PD, Kell DB. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception of the rule? Nat Rev Drug Discov 2008;7:205-20
   PubMed Web of Science ®Google Scholar
• Sugano K, Kansy M, Artusson P, et al. Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 2010;9:597-614
   PubMed Web of Science ®Google Scholar
• Kell DB, Dobson PD, Bilsland E, Oliver SG. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Disc Today 2013;18:218-39
   PubMed Web of Science ®Google Scholar